Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
AssigneeThe Curators of the University of Missouri
InventorsAshim Mitra, Soumyajit Majumdar, Ritesh Jain, Yasser Nashed
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Curators of the University of Missouri
InventorsAshim Mitra, Soumyajit Majumdar, Ritesh Jain, Yasser Nashed
Estimating the term…
Amino acid ester, dipeptide, and tripeptide ester derivatives of bioactive agents are provided wherein said parent agents are substrates effluxed by the P-gp transporter. The derivatives are useful in treating the same condition as the bioactve agent. Also disclosed is a method for preparing a bioactive agent for targeted delivery by nutrient or peptide transporters comprising linking the agent to one or more groups of the formula —X—Y(n)-Z(n′)-Z′(n″)-R; wherein each X, Y, Z, and Z′ is independently Met, Val, Thr, Tyr, Trp, Ser, Ala or Gly; R is independently H or an amino-protecting group; and each n, n′, or n″ is independently 0 or 1.
A compound of formula (I):
A method of treating a patient for a condition wherein the bioactive agent of choice is DRUG, wherein DRUG is a substrate that is effluxed by the P-gp transporter;
A method for enhancing delivery to cells of a bioactive agent, wherein said bioactive agent is DRUG, wherein DRUG is effluxed from said cells by the P-gp transporter, comprising administering to the cells an effective amount of a compound of formula (I):
A method of increasing the bioavailability in a mammalian patient of a bioactive agent, wherein said bioactive agent is DRUG, comprising administering to the patient an effective amount of the compound of formula (I):
A method of increasing the concentration of a bioactive agent in sanctuary sites of a mammalian patient, wherein said bioactive agent is DRUG, comprising administering to the patient an effective amount of the compound of formula (I):
Dependencies are inferred from the claim text.